DEMİR, E. Et Al. 2022. A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.2 , 445-448.

DEMİR, E., SÜTCÜOĞLU, O., DEMİR, B., ÜNSAL, O., & YAZICI, O., (2022). A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma. JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.2, 445-448.

DEMİR, EMRE Et Al. "A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma," JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.2, 445-448, 2022

DEMİR, EMRE Et Al. "A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.2, pp.445-448, 2022

DEMİR, E. Et Al. (2022) . "A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma." JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.2, pp.445-448.

@article{article, author={EMRE DEMİR Et Al. }, title={A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma}, journal={JOURNAL OF ONCOLOGY PHARMACY PRACTICE}, year=2022, pages={445-448} }